The COVID-19 pandemic has confirmed the strategic rationale underlying many hospital and health system mergers and acquisitions and may be acting as a catalyst for innovative strategic partnerships and tactical transactions, according to a new report by management consultancy KaufmanHall.

The report looks at key M&A trends as the pandemic compels health care organizations to focus on core business strengths, build partnerships and strengthen intellectual capital resources.

With respect to building partnerships, it says the COVID-19 crisis “should encourage healthcare leaders, federal and state legislators, and government agencies to reevaluate gaps in the nation’s healthcare infrastructure and recognize the value of building new partnerships to support a healthcare system that can provide high-quality care, accessible to all.”

Related News Articles

Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…